LINC02802

Across TCGA pan-cancer cohorts, LINC02802 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LINC02802 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02802 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02802 expression acts as an unfavorable survival marker, although some lineages such as ESCA and PCPG show a favorable association.

LUAD, MESO, and KIRP are the cancer types where LINC02802 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.597	0.733	<.001	90	view →
MESO	OS	Median	All	0.429	0.652	<.001	68	view →
KIRP	DFS	Median	II,III,IV	0.487	0.870	<.001	59	view →
ACC	DFS	Median	All	0.416	0.736	<.001	53	view →
LUSC	OS	Quartile	III,IV	0.296	0.719	<.001	36	view →
LIHC	OS	Quartile	All	0.674	0.843	.001	35	view →
STAD	OS	Quartile	All	0.372	0.672	.014	31	view →
COAD	DFS	Quartile	All	0.639	0.859	<.001	29	view →
UCEC	DFS	Tertile	All	0.771	0.879	.002	26	view →
CESC	OS	Quartile	All	0.779	0.942	.001	22	view →
GBM	DFS	Median	All	0.190	0.327	<.001	21	view →
UVM	OS	Median	All	0.423	0.835	.015	19	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

LINC02802–LUAD (DFS)

Open the LUAD breakdown →